Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tret Therapeutics
Boston, Massachusetts, United Statestrettx.com ↗
- Ownership
- Private
- Development stage
- Preclinical
01
Overview
Tret Therapeutics specializes in designing highly bioavailable oral dosage forms to enhance the absorption of drugs in development. The company leverages expertise from Northeastern University’s Advanced Drug Delivery Research Lab and collaborates with pharmaceutical partners to address formulation challenges that can hinder clinical success[1][3].
- Therapeutic areas
- Other
- Modalities
- Oral drug formulations
- Industry
- Drug Discovery Services
02
Partnerships
Pharmaceutical partners seeking improved oral drug delivery solutions[3]. Specific names not disclosed.
Beyond the preview
Go deeper on Tret Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tret Therapeutics.